TrialJournal of addiction medicine

Baseline Moderators of Response to Naltrexone and Bupropion in the Treatment of Methamphetamine Use Disorder: An ADAPT-2 Study.

Thomas Carmody et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.